{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T21:56:33Z","timestamp":1789163793371,"version":"build-2803163510"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejinme.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.ejim.2016.12.015","type":"journal-article","created":{"date-parts":[[2016,12,28]],"date-time":"2016-12-28T10:16:34Z","timestamp":1482920194000},"page":"17-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":121,"special_numbering":"C","title":["Subclinical hypothyroidism, lipid metabolism and cardiovascular disease"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1729-8969","authenticated-orcid":false,"given":"Alessandro P","family":"Delitala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Fanciulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Maioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Delitala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ejim.2016.12.015_bb0005","first-page":"1135","article-title":"Thyroid hormone receptor and lipid regulation","volume":"11","author":"Webb","year":"2010","journal-title":"Curr Opin Investig Drugs"},{"issue":"3","key":"10.1016\/j.ejim.2016.12.015_bb0010","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.tem.2009.11.004","article-title":"Thyroid hormone crosstalk with nuclear receptor signaling in metabolic regulation","volume":"21","author":"Liu","year":"2010","journal-title":"Trends Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ejim.2016.12.015_bb0015","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1001\/jama.291.2.228","article-title":"Subclinical thyroid disease: scientific review and guidelines for diagnosis and management","volume":"291","author":"Surks","year":"2004","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ejim.2016.12.015_bb0020","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1530\/EJE-14-0182","article-title":"Prevalence of unknown thyroid disorders in a Sardinian cohort","volume":"171","author":"Delitala","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.ejim.2016.12.015_bb0025","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000356507","article-title":"2013 ETA guideline: management of Subclinical Hypothyroidism","volume":"2","author":"Pearce","year":"2013","journal-title":"Eur Thyroid J"},{"issue":"2","key":"10.1016\/j.ejim.2016.12.015_bb0030","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000362597","article-title":"2014 European thyroid association guidelines for the management of subclinical hypothyroidism in pregnancy and in children","volume":"3","author":"Lazarus","year":"2014","journal-title":"Eur Thyroid J"},{"issue":"3","key":"10.1016\/j.ejim.2016.12.015_bb0035","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1089\/thy.2000.10.251","article-title":"The value of ultrasonography in predicting autoimmune thyroid disease","volume":"10","author":"Pedersen","year":"2000","journal-title":"Thyroid"},{"issue":"7","key":"10.1016\/j.ejim.2016.12.015_bb0040","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1210\/jcem.87.7.8678","article-title":"Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies","volume":"87","author":"Huber","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.ejim.2016.12.015_bb0045","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1210\/jc.2004-2225","article-title":"Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population","volume":"90","author":"Knudsen","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ejim.2016.12.015_bb0050","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1210\/jc.2013-1315","article-title":"Clinical review: a review of the clinical consequences of variation in thyroid function within the reference range","volume":"98","author":"Taylor","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ejim.2016.12.015_bb0055","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0021-9150(02)00372-6","article-title":"Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial","volume":"166","author":"Christ-Crain","year":"2003","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.ejim.2016.12.015_bb0060","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1210\/jcem.86.2.7221","article-title":"Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism","volume":"86","author":"Chadarevian","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ejim.2016.12.015_bb0065","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3904\/kjim.2011.26.4.432","article-title":"Serum TSH level in healthy Koreans and the association of TSH with serum lipid concentration and metabolic syndrome","volume":"26","author":"Lee","year":"2011","journal-title":"Korean J Intern Med"},{"issue":"1","key":"10.1016\/j.ejim.2016.12.015_bb0070","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1210\/er.2006-0043","article-title":"The clinical significance of subclinical thyroid dysfunction","volume":"29","author":"Biondi","year":"2008","journal-title":"Endocr Rev"},{"issue":"8","key":"10.1016\/j.ejim.2016.12.015_bb0075","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1210\/jc.2008-0167","article-title":"The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a metaanalysis","volume":"93","author":"Razvi","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.ejim.2016.12.015_bb0080","doi-asserted-by":"crossref","first-page":"832","DOI":"10.7326\/0003-4819-148-11-200806030-00225","article-title":"Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality","volume":"148","author":"Ochs","year":"2008","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.ejim.2016.12.015_bb0085","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1365-2265.2004.02088.x","article-title":"Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50years","volume":"61","author":"Kvetny","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.ejim.2016.12.015_bb0090","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1365-2265.2005.02399.x","article-title":"Thyroid dysfunction and serum lipids: a community-based study","volume":"63","author":"Walsh","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.ejim.2016.12.015_bb0095","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1210\/jc.2003-030398","article-title":"Hypothyroidism and atherosclerosis","volume":"88","author":"Cappola","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ejim.2016.12.015_bb0100","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1210\/jc.2012-2180","article-title":"Persistent subclinical hypothyroidism and cardiovascular risk in the elderly: the cardiovascular health study","volume":"98","author":"Hyland","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ejim.2016.12.015_bb0105","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1210\/jc.2012-4065","article-title":"Subclinical hypothyroidism and risk for incident myocardial infarction among postmenopausal women","volume":"98","author":"LeGrys","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.ejim.2016.12.015_bb0110","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1001\/jama.2010.1361","article-title":"Subclinical hypothyroidism and the risk of coronary heart disease and mortality","volume":"304","author":"Rodondi","year":"2010","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ejim.2016.12.015_bb0115","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1089\/thy.2014.0219","article-title":"Subclinical hypothyroidism might worsen the effects of aging on serum lipid profiles: a population-based case-control study","volume":"25","author":"Zhao","year":"2015","journal-title":"Thyroid"},{"issue":"6","key":"10.1016\/j.ejim.2016.12.015_bb0120","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1210\/jc.2012-3818","article-title":"Is subclinical hypothyroidism a cardiovascular risk factor in the elderly?","volume":"98","author":"Pasqualetti","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.ejim.2016.12.015_bb0125","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1111\/jgs.13532","article-title":"Diagnosis and management of subclinical hypothyroidism in elderly adults: a review of the literature","volume":"63","author":"Hennessey","year":"2015","journal-title":"J Am Geriatr Soc"},{"issue":"10","key":"10.1016\/j.ejim.2016.12.015_bb0130","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.1210\/jc.2002-020493","article-title":"Increased central arterial stiffness in hypothyroidism","volume":"87","author":"Obuobie","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ejim.2016.12.015_bb0135","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/cen.12532","article-title":"Serum free thyroxine levels are positively associated with arterial stiffness in the SardiNIA study","volume":"82","author":"Delitala","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.1016\/j.ejim.2016.12.015_bb0140","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1210\/jcem.87.4.8378","article-title":"Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study","volume":"87","author":"Caraccio","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ejim.2016.12.015_bb0145","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/j.atherosclerosis.2008.09.022","article-title":"Thyroid function is associated with carotid intima-media thickness in euthyroid subjects","volume":"204","author":"Takamura","year":"2009","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.ejim.2016.12.015_bb0150","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1365-2265.2007.02943.x","article-title":"Carotid artery intima media thickness is inversely related to serum free thyroxine in euthyroid subjects","volume":"67","author":"Dullaart","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.ejim.2016.12.015_bb0155","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1089\/thy.2007.0165","article-title":"Lack of significant association between intima-media thickness in the carotid artery and serum TSH level","volume":"18","author":"Jorde","year":"2008","journal-title":"Tromso Study Thyroid"},{"issue":"2","key":"10.1016\/j.ejim.2016.12.015_bb0160","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1253\/circj.71.191","article-title":"Characterization of subclinical thyroid dysfunction from cardiovascular and metabolic viewpoints: the Suita study","volume":"71","author":"Takashima","year":"2007","journal-title":"Circ J"},{"issue":"12","key":"10.1016\/j.ejim.2016.12.015_bb0165","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.numecd.2015.09.001","article-title":"No evidence of association between subclinical thyroid disorders and common carotid intima medial thickness or atherosclerotic plaque","volume":"25","author":"Delitala","year":"2015","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"10.1016\/j.ejim.2016.12.015_bb0170","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.atherosclerosis.2008.06.011","article-title":"Hypothyroidism is not associated with increased carotid atherosclerosis when cardiovascular risk factors are accounted for in hyperlipidemic patients","volume":"203","author":"Chiche","year":"2009","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.ejim.2016.12.015_bb0175","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1210\/jc.2011-2532","article-title":"Update in lipid alterations in subclinical hypothyroidism","volume":"97","author":"Pearce","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"36","key":"10.1016\/j.ejim.2016.12.015_bb0180","doi-asserted-by":"crossref","first-page":"34114","DOI":"10.1074\/jbc.M305417200","article-title":"Thyroid hormone regulation and cholesterol metabolism are connected through sterol regulatory element-binding protein-2 (SREBP-2)","volume":"278","author":"Shin","year":"2003","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.ejim.2016.12.015_bb0185","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s11886-004-0054-3","article-title":"Hypothyroidism and dyslipidemia: modern concepts and approaches","volume":"6","author":"Pearce","year":"2004","journal-title":"Curr Cardiol Rep"},{"issue":"14","key":"10.1016\/j.ejim.2016.12.015_bb0190","first-page":"915","article-title":"Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity","volume":"320","author":"Steinberg","year":"1989","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ejim.2016.12.015_bb0195","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0009-9120(96)00069-0","article-title":"Low-density lipoprotein composition and oxidability in atherosclerotic cardiovascular disease","volume":"29","author":"Schreier","year":"1996","journal-title":"Clin Biochem"},{"issue":"2","key":"10.1016\/j.ejim.2016.12.015_bb0200","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1161\/01.CIR.100.2.123","article-title":"Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men","volume":"100","author":"Lempiainen","year":"1999","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ejim.2016.12.015_bb0205","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.trsl.2007.12.006","article-title":"Lipid profile in different degrees of hypothyroidism and effects of levothyroxine replacement in mild thyroid failure","volume":"151","author":"Teixeira Pde","year":"2008","journal-title":"Transl Res"},{"issue":"6","key":"10.1016\/j.ejim.2016.12.015_bb0210","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1530\/eje.0.1450705","article-title":"Lipid profile in subclinical hypothyroidism: is L-thyroxine substitution beneficial?","volume":"145","author":"Efstathiadou","year":"2001","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.ejim.2016.12.015_bb0215","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2265.2008.03509.x","article-title":"Effects of 18months of L-T4 replacement in women with subclinical hypothyroidism","volume":"71","author":"Adrees","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"10.1016\/j.ejim.2016.12.015_bb0220","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1089\/thy.2000.10.803","article-title":"Changes in lipoprotein(a) levels in overt and subclinical hypothyroidism before and during treatment","volume":"10","author":"Tzotzas","year":"2000","journal-title":"Thyroid"},{"issue":"5","key":"10.1016\/j.ejim.2016.12.015_bb0225","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1089\/thy.2006.0302","article-title":"Lipoprotein alterations, hepatic lipase activity, and insulin sensitivity in subclinical hypothyroidism: response to L-T(4) treatment","volume":"17","author":"Brenta","year":"2007","journal-title":"Thyroid"},{"issue":"9","key":"10.1016\/j.ejim.2016.12.015_bb0230","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.amjmed.2004.04.027","article-title":"Disturbed metabolism of remnant lipoproteins in patients with subclinical hypothyroidism","volume":"117","author":"Ito","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.ejim.2016.12.015_bb0235","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003419.pub2","article-title":"Thyroid hormone replacement for subclinical hypothyroidism","volume":"3","author":"Villar","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.ejim.2016.12.015_bb0240","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/thy.2006.0208","article-title":"An examination of the relationship between normal range thyrotropin and cardiovascular risk parameters: a study in healthy women","volume":"17","author":"Waterhouse","year":"2007","journal-title":"Thyroid"},{"key":"10.1016\/j.ejim.2016.12.015_bb0245","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1476-511X-11-17","article-title":"Role of extrathyroidal TSHR expression in adipocyte differentiation and its association with obesity","volume":"11","author":"Lu","year":"2012","journal-title":"Lipids Health Dis"},{"issue":"4","key":"10.1016\/j.ejim.2016.12.015_bb0250","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.metabol.2009.08.018","article-title":"Thyroid-stimulating hormone stimulates lipolysis in adipocytes in culture and raises serum free fatty acid levels in vivo","volume":"59","author":"Gagnon","year":"2010","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.ejim.2016.12.015_bb0255","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/hep.23800","volume":"52","author":"Tian","year":"2010","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.ejim.2016.12.015_bb0260","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.amjmed.2005.09.028","article-title":"Subclinical hypothyroidism and the risk of coronary heart disease: a meta-analysis","volume":"119","author":"Rodondi","year":"2006","journal-title":"Am J Med"},{"issue":"9","key":"10.1016\/j.ejim.2016.12.015_bb0265","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.295.9.1033","article-title":"Thyroid status, cardiovascular risk, and mortality in older adults","volume":"295","author":"Cappola","year":"2006","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ejim.2016.12.015_bb0270","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1743-7075-9-44","article-title":"Thyroid stimulating hormone, independent of thyroid hormone, can elevate the serum total cholesterol level in patients with coronary heart disease: a cross-sectional design","volume":"9","author":"Xu","year":"2012","journal-title":"Nutr Metab (Lond)"},{"issue":"11","key":"10.1016\/j.ejim.2016.12.015_bb0275","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1089\/thy.2012.0013","article-title":"Age and gender substantially influence the relationship between thyroid status and the lipoprotein profile: results from a large cross-sectional study","volume":"22","author":"Tognini","year":"2012","journal-title":"Thyroid"},{"issue":"8","key":"10.1016\/j.ejim.2016.12.015_bb0280","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1210\/jc.2012-1133","article-title":"Thyroid-stimulating hormone levels within the reference range are associated with serum lipid profiles independent of thyroid hormones","volume":"97","author":"Wang","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ejim.2016.12.015_bb0285","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/cen.12216","article-title":"A cross-sectional study of the association between circulating TSH level and lipid profile in a large Spanish population","volume":"79","author":"Santos-Palacios","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ejim.2016.12.015_bb0290","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.maturitas.2016.07.003","article-title":"Menopause modulates the association between thyrotropin levels and lipid parameters: the SardiNIA study","volume":"92","author":"Delitala","year":"2016","journal-title":"Maturitas"},{"key":"10.1016\/j.ejim.2016.12.015_bb0295","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJM193012252032601","article-title":"Blood cholesterol values in hyperthyroidism and hypothyroidism - their significance","volume":"203","author":"Mason","year":"1930","journal-title":"N Engl J Med"},{"issue":"6960","key":"10.1016\/j.ejim.2016.12.015_bb0300","first-page":"120","article-title":"Long-term effect of dried thyroid on serum-lipoprotein and serum-cholesterol levels","volume":"272","author":"Galioni","year":"1957","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ejim.2016.12.015_bb0305","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/jama.1972.03200070084015","volume":"220","year":"1972","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ejim.2016.12.015_bb0310","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1016\/j.bbagen.2012.06.003","article-title":"Thyroid hormone receptors: the challenge of elucidating isotype-specific functions and cell-specific response","volume":"1830","author":"Flamant","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"6098","key":"10.1016\/j.ejim.2016.12.015_bb0315","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/324641a0","article-title":"The c-erb-A gene encodes a thyroid hormone receptor","volume":"324","author":"Weinberger","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.ejim.2016.12.015_bb0320","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1111\/j.1440-1681.1998.tb02293.x","article-title":"Molecular and structural biology of thyroid hormone receptors","volume":"25","author":"Apriletti","year":"1998","journal-title":"Clin Exp Pharmacol Physiol Suppl"},{"issue":"10","key":"10.1016\/j.ejim.2016.12.015_bb0325","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1056\/NEJMoa0905633","article-title":"Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia","volume":"362","author":"Ladenson","year":"2010","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ejim.2016.12.015_bb0330","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1210\/endo-125-1-459","volume":"125","author":"Day","year":"1989","journal-title":"Endocrinology"},{"issue":"8","key":"10.1016\/j.ejim.2016.12.015_bb0335","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1210\/me.2002-0009","article-title":"Requirement for thyroid hormone receptor beta in T3 regulation of cholesterol metabolism in mice","volume":"16","author":"Gullberg","year":"2002","journal-title":"Mol Endocrinol"},{"issue":"9","key":"10.1016\/j.ejim.2016.12.015_bb0340","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1210\/en.2006-0116","article-title":"Mouse sterol response element binding protein-1c gene expression is negatively regulated by thyroid hormone","volume":"147","author":"Hashimoto","year":"2006","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.ejim.2016.12.015_bb0345","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1053\/j.gastro.2008.01.032","article-title":"Dramatically increased intestinal absorption of cholesterol following hypophysectomy is normalized by thyroid hormone","volume":"134","author":"Galman","year":"2008","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.ejim.2016.12.015_bb0350","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S2213-8587(14)70006-3","article-title":"Eprotirome in patients with familial hypercholesterolaemia (the AKKA trial): a randomised, double-blind, placebo-controlled phase 3 study","volume":"2","author":"Sjouke","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.1016\/j.ejim.2016.12.015_bb0355","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1210\/jc.2014-3586","article-title":"Thyroid function in the euthyroid range and adverse outcomes in older adults","volume":"100","author":"Cappola","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.ejim.2016.12.015_bb0360","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1210\/jc.2015-3191","article-title":"Subclinical thyroid dysfunction and frailty among older men","volume":"100","author":"Virgini","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ejim.2016.12.015_bb0365","doi-asserted-by":"crossref","first-page":"457","DOI":"10.17219\/acem\/38555","article-title":"Evaluation of selected atherosclerosis risk factors in women with subclinical hypothyroidism treated with L-thyroxine","volume":"25","author":"Adamarczuk-Janczyszyn","year":"2016","journal-title":"Adv Clin Exp Med"},{"issue":"8","key":"10.1016\/j.ejim.2016.12.015_bb0370","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1089\/thy.2016.0010","article-title":"A worthy finding: decrease in total cholesterol and low-density lipoprotein cholesterol in treated mild subclinical hypothyroidism","volume":"26","author":"Zhao","year":"2016","journal-title":"Thyroid"},{"issue":"7","key":"10.1016\/j.ejim.2016.12.015_bb0375","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/ijcp.12394","article-title":"The effect of L-thyroxine substitution on lipid profile, glucose homeostasis, inflammation and coagulation in patients with subclinical hypothyroidism","volume":"68","author":"Anagnostis","year":"2014","journal-title":"Int J Clin Pract"},{"issue":"6","key":"10.1016\/j.ejim.2016.12.015_bb0380","doi-asserted-by":"crossref","first-page":"364","DOI":"10.5455\/medarh.2012.66.364-368","article-title":"Effects of treatment with l-thyroxin on glucose regulation in patients with subclinical hypothyroidism","volume":"66","author":"Bilic-Komarica","year":"2012","journal-title":"Med Arch"},{"issue":"1","key":"10.1016\/j.ejim.2016.12.015_bb0385","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1507\/endocrj.EJ12-0226","article-title":"Effect of l-thyroxine replacement on apolipoprotein B-48 in overt and subclinical hypothyroid patients","volume":"60","author":"Ito","year":"2013","journal-title":"Endocr J"},{"issue":"8","key":"10.1016\/j.ejim.2016.12.015_bb0390","first-page":"1321","article-title":"Effects of thyroxine replacement on endothelial function and carotid artery intima-media thickness in female patients with mild subclinical hypothyroidism","volume":"66","author":"Cabral","year":"2011","journal-title":"Clinics (Sao Paulo)"},{"issue":"1","key":"10.1016\/j.ejim.2016.12.015_bb0395","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s12020-011-9446-5","article-title":"Insulin sensitivity, plasma adiponectin and sICAM-1 concentrations in patients with subclinical hypothyroidism: response to levothyroxine therapy","volume":"40","author":"Kowalska","year":"2011","journal-title":"Endocrine"},{"issue":"4","key":"10.1016\/j.ejim.2016.12.015_bb0400","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1089\/thy.2010.0313","article-title":"Lipid metabolism in subclinical hypothyroidism: plasma kinetics of triglyceride-rich lipoproteins and lipid transfers to high-density lipoprotein before and after levothyroxine treatment","volume":"21","author":"Sigal","year":"2011","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.ejim.2016.12.015_bb0405","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1507\/endocrj.K09E-315","article-title":"Lipid profiles in the untreated patients with Hashimoto thyroiditis and the effects of thyroxine treatment on subclinical hypothyroidism with Hashimoto thyroiditis","volume":"57","author":"Tagami","year":"2010","journal-title":"Endocr J"},{"issue":"8","key":"10.1016\/j.ejim.2016.12.015_bb0410","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1089\/thy.2007.0359","article-title":"The effect of levothyroxine on arterial stiffness and lipid profile in patients with subclinical hypothyroidism","volume":"18","author":"Peleg","year":"2008","journal-title":"Thyroid"},{"issue":"5","key":"10.1016\/j.ejim.2016.12.015_bb0415","doi-asserted-by":"crossref","first-page":"570","DOI":"10.4158\/EP.14.5.570","article-title":"Increased atherogenic low-density lipoprotein cholesterol in untreated subclinical hypothyroidism","volume":"14","author":"Mikhail","year":"2008","journal-title":"Endocr Pract"},{"issue":"2","key":"10.1016\/j.ejim.2016.12.015_bb0420","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1210\/jc.2006-1605","article-title":"Effect of levo-thyroxine replacement on non-high-density lipoprotein cholesterol in hypothyroid patients","volume":"92","author":"Ito","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ejim.2016.12.015_bb0425","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2796.2006.01652.x","article-title":"Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromso Study","volume":"260","author":"Iqbal","year":"2006","journal-title":"J Intern Med"},{"issue":"1","key":"10.1016\/j.ejim.2016.12.015_bb0430","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4158\/EP.12.1.5","article-title":"Levothyroxine replacement therapy in patients with subclinical hypothyroidism and coronary artery disease","volume":"12","author":"Fadeyev","year":"2006","journal-title":"Endocr Pract"},{"issue":"10","key":"10.1016\/j.ejim.2016.12.015_bb0435","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/BF03347530","article-title":"The effect of L-thyroxine replacement therapy on lipid based cardiovascular risk in subclinical hypothyroidism","volume":"27","author":"Serter","year":"2004","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"10.1016\/j.ejim.2016.12.015_bb0440","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1530\/eje.1.01857","article-title":"Effects of levothyroxine treatment on biochemical and hemostasis parameters in patients with hypothyroidism","volume":"152","author":"Gullu","year":"2005","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"10.1016\/j.ejim.2016.12.015_bb0445","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.metabol.2004.05.016","article-title":"Emerging cardiovascular risk factors in subclinical hypothyroidism: lack of change after restoration of euthyroidism","volume":"53","author":"Perez","year":"2004","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/j.ejim.2016.12.015_bb0450","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1210\/jc.2003-031669","article-title":"Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo-controlled study","volume":"89","author":"Monzani","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ejim.2016.12.015_bb0455","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1177\/000331970305400506","article-title":"Subclinical hypothyroidism and lipid abnormalities in older women attending a vascular disease prevention clinic: effect of thyroid replacement therapy","volume":"54","author":"Ganotakis","year":"2003","journal-title":"Angiology"},{"issue":"8","key":"10.1016\/j.ejim.2016.12.015_bb0460","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1210\/jc.2003-030039","article-title":"Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy","volume":"88","author":"Taddei","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ejim.2016.12.015_bb0465","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1089\/105072503321669857","article-title":"Lipoprotein (a) levels and apolipoprotein (a) isoform size in patients with subclinical hypothyroidism: effect of treatment with levothyroxine","volume":"13","author":"Milionis","year":"2003","journal-title":"Thyroid"},{"issue":"5","key":"10.1016\/j.ejim.2016.12.015_bb0470","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0002-9343(02)01022-7","article-title":"A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidism","volume":"112","author":"Kong","year":"2002","journal-title":"Am J Med"},{"issue":"10","key":"10.1016\/j.ejim.2016.12.015_bb0475","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1210\/jcem.86.10.7973","article-title":"TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study)","volume":"86","author":"Meier","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ejim.2016.12.015_bb0480","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0009-8981(98)00074-6","article-title":"Sex steroids, lipids, and lipoprotein cholesterols in women with subclinical and overt hypothyroidism before and after L-thyroxine therapy","volume":"275","author":"Paoli","year":"1998","journal-title":"Clin Chim Acta"},{"issue":"6","key":"10.1016\/j.ejim.2016.12.015_bb0485","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1507\/endocrj.43.731","article-title":"Lipoprotein(a) concentration in subclinical hypothyroidism before and after levo-thyroxine therapy","volume":"43","author":"Yildirimkaya","year":"1996","journal-title":"Endocr J"},{"issue":"3","key":"10.1016\/j.ejim.2016.12.015_bb0490","first-page":"183","article-title":"Effect of L-thyroxine administration on antithyroid antibody levels, lipid profile, and thyroid volume in patients with Hashimoto's thyroiditis","volume":"6","author":"Romaldini","year":"1996","journal-title":"Thyroid"},{"issue":"12","key":"10.1016\/j.ejim.2016.12.015_bb0495","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/0026-0495(95)90075-6","article-title":"Effect of L-thyroxine therapy on lipoprotein fractions in overt and subclinical hypothyroidism, with special reference to lipoprotein(a)","volume":"44","author":"Arem","year":"1995","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.ejim.2016.12.015_bb0500","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1530\/acta.0.1280202","article-title":"Subclinical hypothyroidism and hyperlipoproteinaemia: indiscriminate L-thyroxine treatment not justified","volume":"128","author":"Bogner","year":"1993","journal-title":"Acta Endocrinol"},{"issue":"10","key":"10.1016\/j.ejim.2016.12.015_bb0505","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1001\/archinte.1990.00390210077017","article-title":"Lipoprotein and apolipoprotein levels in subclinical hypothyroidism. Effect of levothyroxine therapy","volume":"150","author":"Arem","year":"1990","journal-title":"Arch Intern Med"},{"issue":"12","key":"10.1016\/j.ejim.2016.12.015_bb0510","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/BF02598988","article-title":"Does treatment with L-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism?","volume":"11","author":"Jaeschke","year":"1996","journal-title":"J Gen Intern Med"},{"issue":"7","key":"10.1016\/j.ejim.2016.12.015_bb0515","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2169\/internalmedicine.33.413","article-title":"Disturbed lipid metabolism in patients with subclinical hypothyroidism: effect of L-thyroxine therapy","volume":"33","author":"Miura","year":"1994","journal-title":"Intern Med"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620516304447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620516304447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T21:18:29Z","timestamp":1568668709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620516304447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":103,"alternative-id":["S0953620516304447"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2016.12.015","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subclinical hypothyroidism, lipid metabolism and cardiovascular disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2016.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}